The pharmaceutical industry demands absolute results and extensive supportive documentation as the decisions based on the analytical results can have significant repercussions on public health, product quality, regulatory compliance, and the client’s financial status. Services provided by Brooks Applied Labs have supported drug release testing, clean up efficiencies of catalysts, impurity identification, lot monitoring, and investigations into bioreactor performance variability.
Through our experience with nearly all facets of the industry our involvement has significantly reduced resources expended by our clients on method development/validation, synthesis inefficiencies, side product formation, API stability, amongst a plethora of other topics.
Intermediates, active pharmaceutical ingredients, and delivered drugs including excipients can be quite complex requiring extensive knowledge regarding the target analyte and the applicable methodologies for dissolution and analysis of the materials. Scientists at Brooks Applied Labs have the knowledge and experience to identify the most appropriate techniques for analysis of the most complex pharmaceutical molecules and target elements as we have tested thousands of different materials over the years.
The science behind Brooks Applied Labs is complemented by the oversight of our experienced and dedicated quality assurance department. Brooks Applied Labs is continually being audited by our pharmaceutical clients to ensure cGMP compliance and implementation, as well as execution of quality requirements set forth by the Code of Federal Regulations (CFR) and the International Conference on Harmonization (ICH). We understand our compliance equates to a higher quality service and greater defensibility to support your processes.
Contact us to find out how your quality and process objectives can be met more efficiently than ever.